Mauricio Yonamine

Mauricio Yonamine

Auto-generated profile, based on publicly available information

Mauricio Yonamine

Departamento de Análises Clínicas e Toxicológicas, Faculdade de Ciências Farmacêuticas, Universidade de São Paulo, São Paulo, Brazil

Research Focus & Metrics

Academic Career Length

25Years (2002-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 June 2018 in Psychological Medicine
Verified
Journal Article
Open access
PDF file
FPFernanda Palhano-Fontes
Fernanda Palhano-Fontes
DBDayanna Barreto
Dayanna Barreto
HOHeloisa Onias
Heloisa Onias
KAKatia C. Andrade
Katia C. Andrade
MNMorgana M. Novaes
Morgana M. Novaes
DADráulio B. Araújo
Dráulio B. Araújo
Background: Recent open-label trials show that psychedelics, such as ayahuasca, hold promise as fast-onset antidepressants in treatment-resistant depression.Methods: To test the antidepressant effects of ayahuasca, we conducted a parallel-arm, double-blind randomized placebo-controlled trial in 29 patients with treatment-resistant depression. Patients received a single dose of either ayahuasca or placebo. We assessed changes in depression severity with the Montgomery-Åsberg Depression Rating Scale (MADRS) and the Hamilton Depression Rating scale at baseline, and at 1 (D1), 2 (D2), and 7 (D7) days after dosing.Results: We observed significant antidepressant effects of ayahuasca when compared with placebo at all-time points. MADRS scores were significantly lower in the ayahuasca group compared with placebo at D1 and D2 (p= 0.04), and at D7 (p< 0.0001). Between-group effect sizes increased from D1 to D7 (D1: Cohen'sd= 0.84; D2: Cohen'sd= 0.84; D7: Cohen'sd= 1.49). Response rates were high for both groups at D1 and D2, and significantly higher in the ayahuasca group at D7 (64%v.27%;p= 0.04). Remission rate showed a trend toward significance at D7 (36%v.7%,p= 0.054).Conclusions: To our knowledge, this is the first controlled trial to test a psychedelic substance in treatment-resistant depression. Overall, this study brings new evidence supporting the safety and therapeutic value of ayahuasca, dosed within an appropriate setting, to help treat depression. This study is registered athttp://clinicaltrials.gov(NCT02914769).

30 September 2015 in PLOS ONE
Verified
Journal Article
Open access
PDF file
ESEduardo Ekman Schenberg
Eduardo Ekman Schenberg
JAJoão Felipe Morel Alexandre
João Felipe Morel Alexandre
RFRenato Filev
Renato Filev
ACAndre Mascioli Cravo
Andre Mascioli Cravo
JSJoão Ricardo Sato
João Ricardo Sato
DSDartiu Xavier da Silveira
Dartiu Xavier da Silveira
Ritual use of ayahuasca, an amazonian Amerindian medicine turned sacrament in syncretic religions in Brazil, is rapidly growing around the world. Because of this internationalization, a comprehensive understanding of the pharmacological mechanisms of action of the brew and the neural correlates of the modified states of consciousness it induces is important. Employing a combination of electroencephalogram (EEG) recordings and quantification of ayahuasca's compounds and their metabolites in the systemic circulation we found ayahuasca to induce a biphasic effect in the brain. This effect was composed of reduced power in the alpha band (8–13 Hz) after 50 minutes from ingestion of the brew and increased slow- and fast-gamma power (30–50 and 50–100 Hz, respectively) between 75 and 125 minutes. Alpha power reductions were mostly located at left parieto-occipital cortex, slow-gamma power increase was observed at left centro-parieto-occipital, left fronto-temporal and right frontal cortices while fast-gamma increases were significant at left centro-parieto-occipital, left fronto-temporal, right frontal and right parieto-occipital cortices. These effects were significantly associated with circulating levels of ayahuasca’s chemical compounds, mostly N,N-dimethyltryptamine (DMT), harmine, harmaline and tetrahydroharmine and some of their metabolites. An interpretation based on a cognitive and emotional framework relevant to the ritual use of ayahuasca, as well as it's potential therapeutic effects is offered.

1 June 2007 in Journal of Chromatography B
Verified
Journal Article
Closed access
RARafael Menck de Almeida
Rafael Menck de Almeida
MYMauricio Yonamine
Mauricio Yonamine


12 January 2009 in Phytochemical Analysis
Verified
Journal Article
Open access
PDF file
APAna Paula Salum Pires
Ana Paula Salum Pires
COCarolina Dizioli Rodrigues De Oliveira
Carolina Dizioli Rodrigues De Oliveira
SMSidnei Moura
Sidnei Moura
FDFelipe Dorr
Felipe Dorr
WSWagner Abreu E. Silva
Wagner Abreu E. Silva
MYMauricio Yonamine
Mauricio Yonamine
Introduction: Ayahuasca is obtained by infusing the pounded stems of Banisteriopsis caapi in combination with the leaves of Psychotria viridis. P. viridis is rich in the psychedelic indole N,N‐dimethyltryptamine, whereas B. caapi contains substantial amounts of β‐carboline alkaloids, mainly harmine, harmaline and tetrahydroharmine, which are monoamine‐oxidase inhibitors. Because of differences in composition in ayahuasca preparations, a method to measure their main active constituents is needed.Objective: To develop a gas chromatographic method for the simultaneous determination of dimethyltryptamine and the main β‐carbolines found in ayahuasca preparations.Methodology: The alkaloids were extracted by means of solid phase extraction (C18) and detected by gas chromatography with nitrogen/phosphorous detector.Results: The lower limit of quantification (LLOQ) was 0.02 mg/mL for all analytes. The calibration curves were linear over a concentration range of 0.02–4.0 mg/mL (r2 > 0.99). The method was also precise (RSD < 10%).Conclusion: A simple gas chromatographic method to determine the main alkaloids found in ayahuasca was developed and validated. The method can be useful to estimate administered doses in animals and humans for further pharmacological and toxicological investigations of ayahuasca. Copyright © 2009 John Wiley & Sons, Ltd.

1 February 2015 in Forensic Science International
Verified
Journal Article
Closed access
SLSilvio Fernandes Lapachinske
Silvio Fernandes Lapachinske
GOGuilherme Gonçalves Okai
Guilherme Gonçalves Okai
ASAriana dos Santos
Ariana dos Santos
ABAndré Valle de Bairros
André Valle de Bairros
MYMauricio Yonamine
Mauricio Yonamine